Medications like Wegovy and Zepbound receive plenty of buzz for their ability to help people lose weight. The two have a few things in common, mainly, peptides for weight loss. Wegovy belongs to a class of medications known as glucagon-like peptide-1 , and Zepbound is both a GLP-1 and glucose-dependent insulinotropic polypeptide . But here’s the thing: Not all peptides are designed for weight loss, although research has found that it’s usually a common side effect.
Semaglutide is a GLP-1 receptor agonist and includes Ozempic and obesity . Both are injectable medications approved by the Food and Drug Administration . The Ozempic website points out that people on the drug have lost up to 14 pounds, but also stresses that it’s “not a weight loss drug.” The Wegovy website also says that adults on average lose about 15% of their body weight or 35 pounds on the medication—and this one is approved for weight loss. Tirzepetide .